Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Testosterone's effects on COVID-19 are unclear and need more research.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Women are more likely to have long-term post-COVID symptoms than men.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

COVID-19 infection can significantly cause temporary hair loss.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

AGA linked to worse COVID-19 outcomes in men.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Possible link between androgens and COVID-19 severity; more research needed.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

About 61% of women who had COVID-19 experienced hair loss afterward.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.